Trial Profile

A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of the Dose-Response Profile of A-101 Topical Solution in Subjects With Seborrheic Keratosis of the Face

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 19 Nov 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Hydrogen peroxide (Primary)
Indications Seborrhoeic keratosis
Focus Therapeutic Use
Sponsors Aclaris Therapeutics

Most Recent Events

19 Sep 2017 According to an Aclaris Therapeutics media release, data have been published in the journal Dermatologic Surgery.
19 Sep 2017 Results presented in a Aclaris Therapeutics Media Release.
17 Mar 2015 Status changed from active, no longer recruiting to completed, based on the results published in Aclaris Therapeutics media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com